These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 4269702
1. Immunotherapy in patients with melanoma. Seiger HF, Shingleton WW, Metzgar RS, Buckley CE. Ann Surg; 1973 Sep; 178(3):352-9. PubMed ID: 4269702 [No Abstract] [Full Text] [Related]
2. New approach to immunotherapy of melanoma. Brandes LJ, Galton DA, Wiltshaw E. Lancet; 1971 Aug 07; 2(7719):293-5. PubMed ID: 4104979 [No Abstract] [Full Text] [Related]
3. Immunological studies on malignant melanomas of man. Romsdahl MM, Cox IS. Yale J Biol Med; 1973 Dec 07; 46(5):693-701. PubMed ID: 4205125 [No Abstract] [Full Text] [Related]
4. Adoptive transfer and specific active immunization of patients with malignant melanoma. Seigler H, Buckley CE, Sheppard LB, Horne BJ, Shingleton WW. Ann N Y Acad Sci; 1976 Dec 07; 277(00):522-32. PubMed ID: 1069561 [No Abstract] [Full Text] [Related]
5. Effectors of immunologic responses: their expression and modes of action in skin. Parish WE. Adv Biol Skin; 1971 Dec 07; 11():1-28. PubMed ID: 4124138 [No Abstract] [Full Text] [Related]
6. Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response. Chess L, Bock GN, Ungaro PC, Buchholz DH, Mardiney MR. J Natl Cancer Inst; 1973 Jul 07; 51(1):57-65. PubMed ID: 4720886 [No Abstract] [Full Text] [Related]
7. Immunology and cutaneous malignant melanoma. Sober AJ. Int J Dermatol; 1976 Jul 07; 15(1):1-18. PubMed ID: 1107238 [No Abstract] [Full Text] [Related]
8. Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment. Seigler HF, Shingleton WW, Pickrell KL. Plast Reconstr Surg; 1975 Mar 07; 55(3):294-8. PubMed ID: 1118487 [Abstract] [Full Text] [Related]
9. Immunologic evaluation of the cancer patient during immunotherapy. Boehm OR, Boehm BJ, Jewell WR, Humphrey LJ. Natl Cancer Inst Monogr; 1972 Dec 07; 35():403-8. PubMed ID: 4633407 [No Abstract] [Full Text] [Related]
10. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look. Bluming AZ, Vogel CL, Ziegler JL, Kiryabwire JW. J Natl Cancer Inst; 1972 Jan 07; 48(1):17-24. PubMed ID: 4652371 [No Abstract] [Full Text] [Related]
11. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy]. Trapeznikov NN, Iavorskiĭ VV, Kadagidze ZG, Malaev SG, Kupin VI. Vopr Onkol; 1977 Jan 07; 23(8):27-33. PubMed ID: 906404 [Abstract] [Full Text] [Related]
13. Delayed hypersensitivity to Trichinella spiralis. 3. Effect of repeated sensitizations in donors and recipients. Kim CW, Jamuar MP, Hamilton LD. J Immunol; 1970 Jul 07; 105(1):175-86. PubMed ID: 4246565 [No Abstract] [Full Text] [Related]
14. Immunopathologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation BCG: correlation with cell-mediated immunity. Lieberman R, Epstein W, Fudenberg HH. Int J Cancer; 1974 Sep 15; 14(3):401-16. PubMed ID: 4617711 [No Abstract] [Full Text] [Related]
15. Use of skin as a "tool" or convenient milieu to study allergic responses. Ovary Z, Tigelaar RE. Adv Biol Skin; 1971 Sep 15; 11():103-21. PubMed ID: 4268874 [No Abstract] [Full Text] [Related]
18. A possible relationship between delayed hypersensitivity and cell-mediated immunity. Salvin SB, Neta R. Am Rev Respir Dis; 1975 Apr 15; 111(4):373-7. PubMed ID: 47728 [No Abstract] [Full Text] [Related]